1887

Abstract

Trehalose 6,6′-dimycolate (TDM) is a glycolipid component of the mycobacterial cell wall that causes immune responses in mice similar to (MTB) infection, including granuloma formation with production of proinflammatory cytokines. The precise roles of tumour necrosis factor (TNF)-, complement C5 and interleukin (IL)-6 in the molecular events that lead to the initiation and maintenance of the granulomatous response to TDM have not been fully elucidated. Macrophage proinflammatory responses from wild-type and complement-deficient mice after infection with MTB were assessed, and compared to responses from organisms in which surface TDM had been removed. Removal of TDM abolished proinflammatory responses, markedly so in the complement-deficient macrophages. Mice deficient in TNF-, C5a and IL-6, along with wild-type C57BL/6 controls, were intravenously injected with TDM in a water-in-oil emulsion, and analysed for histological response and cytokine production in lungs. Wild-type C57BL/6 mice formed granulomas with increased production of IL-1, IL-6, TNF-, macrophage inflammatory protein-1 (MIP-1), IL-12p40, interferon- (IFN-), and IL-10 protein and mRNA. TNF--deficient mice failed to produce a histological response to TDM, with no increases in cytokine production following TDM administration. While C5a-deficient mice exhibited inflammation, they did not form structured granulomas and initially had decreased production of proinflammatory mediators. IL-6-deficient mice initiated granuloma formation, but failed to maintain the granulomas through day 7 and demonstrated decreased early production of proinflammatory mediators in comparison to wild-type mice. These data suggest that TNF- is critical for initiation of the granulomatous response, C5a is necessary for formation of cohesive granulomas, and IL-6 plays a key role in the granuloma maintenance response to mycobacterial TDM.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.2008/016923-0
2008-06-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/micro/154/6/1813.html?itemId=/content/journal/micro/10.1099/mic.0.2008/016923-0&mimeType=html&fmt=ahah

References

  1. Actor, J. K., Leonard, C. D., Watson, V. E., Wells, A., Jagannath, C., Hunter, R. L., Jr & Dasgupta, A. ( 2000; ). Cytokine mRNA expression and serum cortisol evaluation during murine lung inflammation induced by Mycobacterium tuberculosis. Comb Chem High Throughput Screen 3, 343–351.
    [Google Scholar]
  2. Actor, J. K., Breij, E., Wetsel, R. A., Hoffmann, H., Hunter, R. L., Jr & Jagannath, C. ( 2001; ). A role for complement C5 in organism containment and granulomatous response during murine tuberculosis. Scand J Immunol 53, 464–474.[CrossRef]
    [Google Scholar]
  3. Ahlers, J. D., Belyakov, I. M., Matsui, S. & Berzofsky, J. A. ( 2001; ). Signals delivered through TCR instruct IL-12 receptor (IL-12R) expression: IL-12 and tumor necrosis factor-alpha synergize for IL-12R expression at low antigen dose. Int Immunol 13, 1433–1442.[CrossRef]
    [Google Scholar]
  4. Algood, H. M., Lin, P. L., Yankura, D., Jones, A., Chan, J. & Flynn, J. L. ( 2004; ). TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection. J Immunol 172, 6846–6857.[CrossRef]
    [Google Scholar]
  5. Algood, H. M., Lin, P. L. & Flynn, J. L. ( 2005; ). Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 41 (Suppl. 3), S189–S193.[CrossRef]
    [Google Scholar]
  6. Appelberg, R., Castro, A. G., Pedrosa, J. & Minoprio, P. ( 1994; ). Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice. Immunology 82, 361–364.
    [Google Scholar]
  7. Bermudez, L. E. & Kaplan, G. ( 1995; ). Recombinant cytokines for controlling mycobacterial infections. Trends Microbiol 3, 22–27.[CrossRef]
    [Google Scholar]
  8. Borders, C. W., Courtney, A., Ronen, K., Pilar Laborde-Lahoz, M., Guidry, T. V., Hwang, S. A., Olsen, M., Hunter, R. L., Jr, Hollmann, T. J. & other authors ( 2005; ). Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6′-dimycolate. Scand J Immunol 62, 123–130.[CrossRef]
    [Google Scholar]
  9. Botha, T. & Ryffel, B. ( 2003; ). Reactivation of latent tuberculosis infection in TNF-deficient mice. J Immunol 171, 3110–3118.[CrossRef]
    [Google Scholar]
  10. Cagatay, A. A., Caliskan, Y., Aksoz, S., Gulec, L., Kucukoglu, S., Gagatay, Y., Berk, H., Ozsut, H., Eraksoy, H. & Calangu, S. ( 2004; ). Extrapulmonary tuberculosis in immunocompetent adults. Scand J Infect Dis 36, 799–806.[CrossRef]
    [Google Scholar]
  11. Chensue, S. W., Warmington, K. S., Ruth, J. H., Lincoln, P. & Kunkel, S. L. ( 1995; ). Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Local and regional participation of IFN-γ, IL-10, and TNF. J Immunol 154, 5969–5976.
    [Google Scholar]
  12. Czermak, B. J., Sarma, V., Bless, N. M., Schmal, H., Friedl, H. P. & Ward, P. A. ( 1999; ). In vitro and in vivo dependency of chemokine generation on C5a and TNF-α. J Immunol 162, 2321–2325.
    [Google Scholar]
  13. Dannenberg, A. M., Jr ( 1991; ). Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 12, 228–233.[CrossRef]
    [Google Scholar]
  14. Fleming, S. D., Anderson, J., Wilson, F., Shea-Donohue, T. & Tsokos, G. C. ( 2003; ). C5 is required for CD49d expression on neutrophils and VCAM expression on vascular endothelial cells following mesenteric ischemia/reperfusion. Clin Immunol 106, 55–64.[CrossRef]
    [Google Scholar]
  15. Flesch, I. E., Hess, J. H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H. & Kaufmann, S. H. ( 1995; ). Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med 181, 1615–1621.[CrossRef]
    [Google Scholar]
  16. Florido, M., Cooper, A. M. & Appelberg, R. ( 2002; ). Immunological basis of the development of necrotic lesions following Mycobacterium avium infection. Immunology 106, 590–601.[CrossRef]
    [Google Scholar]
  17. Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schreiber, R., Mak, T. W. & Bloom, B. R. ( 1995; ). Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561–572.[CrossRef]
    [Google Scholar]
  18. Foreman, K. E., Vaporciyan, A. A., Bonish, B. K., Jones, M. L., Johnson, K. J., Glovsky, M. M., Eddy, S. M. & Ward, P. A. ( 1994; ). C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94, 1147–1155.[CrossRef]
    [Google Scholar]
  19. Geisel, R. E., Sakamoto, K., Russell, D. G. & Rhoades, E. R. ( 2005; ). In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates. J Immunol 174, 5007–5015.[CrossRef]
    [Google Scholar]
  20. Gross, V. & Andus, T. ( 1992; ). Human recombinant C5a enhances lipopolysaccharide-induced synthesis of interleukin-6 by human monocytes. Eur J Clin Invest 22, 271–276.[CrossRef]
    [Google Scholar]
  21. Guidry, T. V., Olsen, M., Kil, K. S., Hunter, R. L., Jr, Geng, Y. J. & Actor, J. K. ( 2004; ). Failure of CD1D−/− mice to elicit hypersensitive granulomas to mycobacterial cord factor trehalose 6,6′-dimycolate. J Interferon Cytokine Res 24, 362–371.[CrossRef]
    [Google Scholar]
  22. Guidry, T. V., Hunter, R. L., Jr & Actor, J. K. ( 2006; ). CD3+ cells transfer the hypersensitive granulomatous response to mycobacterial glycolipid trehalose 6,6′-dimycolate in mice. Microbiology 152, 3765–3775.[CrossRef]
    [Google Scholar]
  23. Guler, R., Olleros, M. L., Vesin, D., Parapanov, R. & Garcia, I. ( 2005; ). Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection. Infect Immun 73, 3668–3676.[CrossRef]
    [Google Scholar]
  24. Hernandez-Caselles, T. & Stutman, O. ( 1993; ). Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. J Immunol 151, 3999–4012.
    [Google Scholar]
  25. Hsu, M. H., Wang, M., Browning, D. D., Mukaida, N. & Ye, R. D. ( 1999; ). NF-κB activation is required for C5a-induced interleukin-8 gene expression in mononuclear cells. Blood 93, 3241–3249.
    [Google Scholar]
  26. Hunter, R. L., Olsen, M., Jagannath, C. & Actor, J. K. ( 2006a; ). Trehalose 6,6′-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am J Pathol 168, 1249–1261.[CrossRef]
    [Google Scholar]
  27. Hunter, R. L., Olsen, M. R., Jagannath, C. & Actor, J. K. ( 2006b; ). Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci 36, 371–386.
    [Google Scholar]
  28. Indrigo, J., Hunter, R. L., Jr & Actor, J. K. ( 2002; ). Influence of trehalose 6,6′-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology 148, 1991–1998.
    [Google Scholar]
  29. Indrigo, J., Hunter, R. L., Jr & Actor, J. K. ( 2003; ). Cord factor trehalose 6,6′-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 149, 2049–2059.[CrossRef]
    [Google Scholar]
  30. Jagannath, C., Hoffmann, H., Sepulveda, E., Actor, J. K., Wetsel, R. A. & Hunter, R. L. ( 2000; ). Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand J Immunol 52, 369–379.[CrossRef]
    [Google Scholar]
  31. Kaneko, H., Yamada, H., Mizuno, S., Udagawa, T., Kazumi, Y., Sekikawa, K. & Sugawara, I. ( 1999; ). Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice. Lab Invest 79, 379–386.
    [Google Scholar]
  32. Karp, C. L. & Wills-Karp, M. ( 2001; ). Complement and IL-12: yin and yang. Microbes Infect 3, 109–119.[CrossRef]
    [Google Scholar]
  33. Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N. & Braun, M. M. ( 2001; ). Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345, 1098–1104.[CrossRef]
    [Google Scholar]
  34. Kindler, V., Sappino, A. P., Grau, G. E., Piguet, P. F. & Vassalli, P. ( 1989; ). The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56, 731–740.[CrossRef]
    [Google Scholar]
  35. Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K., Kopf, M. & Kaufmann, S. H. ( 1997; ). Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 65, 4843–4849.
    [Google Scholar]
  36. Livak, K. J. & Schmittgen, T. D. ( 2001; ). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408.[CrossRef]
    [Google Scholar]
  37. Murray, P. J., Aldovini, A. & Young, R. A. ( 1996; ). Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines. Proc Natl Acad Sci U S A 93, 934–939.[CrossRef]
    [Google Scholar]
  38. Nagabhushanam, V., Solache, A., Ting, L. M., Escaron, C. J., Zhang, J. Y. & Ernst, J. D. ( 2003; ). Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-γ. J Immunol 171, 4750–4757.[CrossRef]
    [Google Scholar]
  39. Oiso, R., Fujiwara, N., Yamagami, H., Maeda, S., Matsumoto, S., Nakamura, S., Oshitani, N., Matsumoto, T., Arakawa, T. & Kobayashi, K. ( 2005; ). Mycobacterial trehalose 6,6′-dimycolate preferentially induces type 1 helper T cell responses through signal transducer and activator of transcription 4 protein. Microb Pathog 39, 35–43.[CrossRef]
    [Google Scholar]
  40. Oswald, I. P., Dozois, C. M., Fournout, S., Petit, J. F. & Lemaire, G. ( 1999; ). Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate. Eur Cytokine Netw 10, 533–540.
    [Google Scholar]
  41. Pelletier, M., Forget, A., Bourassa, D., Gros, P. & Skamene, E. ( 1982; ). Immunopathology of BCG infection in genetically resistant and susceptible mouse strains. J Immunol 129, 2179–2185.
    [Google Scholar]
  42. Perez, R. L., Roman, J., Staton, G. W., Jr & Hunter, R. L. ( 1994; ). Extravascular coagulation and fibrinolysis in murine lung inflammation induced by the mycobacterial cord factor trehalose-6,6′-dimycolate. Am J Respir Crit Care Med 149, 510–518.[CrossRef]
    [Google Scholar]
  43. Perez, R. L., Roman, J., Roser, S., Little, C., Olsen, M., Indrigo, J., Hunter, R. L. & Actor, J. K. ( 2000; ). Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6′-dimycolate. J Interferon Cytokine Res 20, 795–804.[CrossRef]
    [Google Scholar]
  44. Ramanathan, V. D., Curtis, J. & Turk, J. L. ( 1980; ). Activation of the alternative pathway of complement by mycobacteria and cord factor. Infect Immun 29, 30–35.
    [Google Scholar]
  45. Rao, V., Gao, F., Chen, B., Jacobs, W. R., Jr & Glickman, M. S. ( 2006; ). Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J Clin Invest 116, 1660–1667.[CrossRef]
    [Google Scholar]
  46. Rincon, M., Anguita, J., Nakamura, T., Fikrig, E. & Flavell, R. A. ( 1997; ). Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 185, 461–469.[CrossRef]
    [Google Scholar]
  47. Roach, D. R., Bean, A. G., Demangel, C., France, M. P., Briscoe, H. & Britton, W. J. ( 2002; ). TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168, 4620–4627.[CrossRef]
    [Google Scholar]
  48. Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Toniatti, C., Puccetti, P., Bistoni, F. & Poli, V. ( 1996; ). Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 183, 1345–1355.[CrossRef]
    [Google Scholar]
  49. Russell, D. G. ( 2007; ). Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5, 39–47.[CrossRef]
    [Google Scholar]
  50. Saunders, B. M., Frank, A. A., Orme, I. M. & Cooper, A. M. ( 2000; ). Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun 68, 3322–3326.[CrossRef]
    [Google Scholar]
  51. Schindler, R., Gelfand, J. A. & Dinarello, C. A. ( 1990; ). Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76, 1631–1638.
    [Google Scholar]
  52. Schulman, E. S., Post, T. J., Henson, P. M. & Giclas, P. C. ( 1988; ). Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J Clin Invest 81, 918–923.[CrossRef]
    [Google Scholar]
  53. Shibuya, K., Robinson, D., Zonin, F., Hartley, S. B., Macatonia, S. E., Somoza, C., Hunter, C. A., Murphy, K. M. & O'Garra, A. ( 1998; ). IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-γ in BALB/c but not C57BL/6 mice. J Immunol 160, 1708–1716.
    [Google Scholar]
  54. Silva, C. L., Ekizlerian, S. M. & Fazioli, R. A. ( 1985; ). Role of cord factor in the modulation of infection caused by mycobacteria. Am J Pathol 118, 238–247.
    [Google Scholar]
  55. Van Snick, J. ( 1990; ). Interleukin-6: an overview. Annu Rev Immunol 8, 253–278.[CrossRef]
    [Google Scholar]
  56. VanHeyningen, T. K., Collins, H. L. & Russell, D. G. ( 1997; ). IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J Immunol 158, 330–337.
    [Google Scholar]
  57. WHO ( 2003; ). Global Tuberculosis Control. Surveillance, Planning, Financing. The World Health Report 2003. Geneva, Switzerland: World Health Organization.
  58. Yamagami, H., Matsumoto, T., Fujiwara, N., Arakawa, T., Kaneda, K., Yano, I. & Kobayashi, K. ( 2001; ). Trehalose 6,6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice. Infect Immun 69, 810–815.[CrossRef]
    [Google Scholar]
  59. Yimin, Kohanawa, M. & Minagawa, T. ( 2003; ). Up-regulation of granulomatous inflammation in interleukin-6 knockout mice infected with Rhodococcus aurantiacus. Immunology 110, 501–506.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.2008/016923-0
Loading
/content/journal/micro/10.1099/mic.0.2008/016923-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error